G. Lerebours

发表

Coronary artery constriction caused by the cold pressor test in human hypertension.

A. Nitenberg, E. Aptecar, I. Antony, 1994, Hypertension.

Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients.

A. Nitenberg, I. Antony, G. Lerebours, 1996, Circulation.

Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine

J. Vilaine, G. Lerebours, E. Canet, 2011, Annals of the New York Academy of Sciences.

Comparison of Outcome Adjudication by Investigators and by a Central End Point Committee in Heart Failure Trials

B. Tyl, M. Komajda, J. Borer, 2020, Circulation. Heart failure.

Acceptability of perindopril in mild-to-moderate chronic congestive heart failure. Results of a long-term open study in 320 patients.

P. Desché, I. Antony, G. Lerebours, 1993, The American journal of cardiology.

Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure. Role of nitric oxide, prostanoids, and oxidant stress.

F. Lallemand, P. Mulder, V. Richard, 1999, Circulation.

Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure : role of nitric oxide, prostanoids, oxidant stress, and bradykinin.

F. Lallemand, P. Mulder, V. Richard, 2000, Circulation.

Impairment of flow-dependent coronary dilation in hypertensive patients. Demonstration by cold pressor test induced flow velocity increase.

A. Nitenberg, E. Aptecar, I. Antony, 1995, American journal of hypertension.

ffect of Perindopril on the Onset and Progression of eft Ventricular Dysfunction in Duchenne Muscular Dystrophy

H. Bécane, C. Meune, J. Devaux, 2005 .

Pharmacological Basics of ƒ-Current Inhibition

G. Lerebours, M. Bouly, F. Mahlberg-Gaudin, 2005, Heart Drug.

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Michael Böhm, Karl Swedberg, Luigi Tavazzi, 2010, The Lancet.

Restoration of flow-dependent coronary dilation by ACE inhibition improves papaverine-induced maximal coronary blood flow in hypertensive patients: demonstration that large epicardial coronary arteries are more than conductance vessels.

D. Chemla, A. Nitenberg, I. Antony, 2000, Journal of cardiovascular pharmacology.

Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise.

J. Ménard, C. Thuillez, R. Joannidés, 2006, British journal of clinical pharmacology.

Evolution of peripheral nerve function in hypoxaemic COPD patients taking almitrine bismesylate: a prospective long-term study.

G. Lerebours, J. Sénant, G. Ozenne, 1987, Bulletin europeen de physiopathologie respiratoire.

Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy.

H. Bécane, D. Duboc, C. Meune, 2005, Journal of the American College of Cardiology.

Clinical review of perindopril in the treatment of hypertension.

I. Antony, G. Lerebours, 1994, The Canadian journal of cardiology.

Antianginal and Antiischemic Effects of Ivabradine, an If Inhibitor, in Stable Angina: A Randomized, Double-Blind, Multicentered, Placebo-Controlled Trial

J. Borer, K. Fox, P. Jaillon, 2003, Circulation.

Neurological toxicity related to pefloxacin.

H. Tilly, J. Lucet, H. Piguet, 1988, The Journal of antimicrobial chemotherapy.

PERIPHERAL NEUROPATHY IN CHRONIC OBSTRUCTIVE LUNG DISEASE

G. Lerebours, N. Moore, J. Sénant, 1985, The Lancet.

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

Michael Böhm, Karl Swedberg, Luigi Tavazzi, 2010, The Lancet.

Long-Term Heart Rate Reduction Induced by the Selective If Current Inhibitor Ivabradine Improves Left Ventricular Function and Intrinsic Myocardial Structure in Congestive Heart Failure

F. Lallemand, P. Mulder, V. Richard, 2004, Circulation.

Effects of angiotensin converting enzyme inhibition on crossbridge properties of diaphragm in cardiomyopathic hamsters of the dilated bio 53-58 strain.

D. Chemla, Y. Lecarpentier, C. Coirault, 1997, American journal of respiratory and critical care medicine.

Loss of flow-dependent coronary artery dilatation in patients with hypertension.

A. Nitenberg, I. Antony, G. Lerebours, 1995, Circulation.

Relationships between heart rate and heart rate variability: study in conscious rats.

F. Carré, B. Swynghedauw, L. Mangin, 1998, Journal of cardiovascular pharmacology.

Impaired skeletal muscle performance in the early stage of cardiac pressure overload in rabbits: beneficial effects of angiotensin-converting enzyme inhibition.

D. Chemla, Y. Lecarpentier, O. Langeron, 1999, The Journal of pharmacology and experimental therapeutics.

[Hypouricemia and hyperuricosuria in chronic decompensated respiratory insufficiency].

J. Leroy, M. Godin, G. Bonmarchand, 1986, Presse medicale.

Clinical acceptability of ACE inhibitor therapy in mild to moderate hypertension, a comparison between perindopril and enalapril

C. Calvo, J. Carillo, G. Lerebours, 1995, Cardiovascular Drugs and Therapy.

Serum hyaluronate in malignant pleural mesothelioma

T. Frebourg, B. Delpech, G. Lerebours, 1987, Cancer.

Antianginal and Antiischemic Effects of Ivabradine, an If Inhibitor, in Stable Angina: A Randomized, Double-Blind, Multicentered, Placebo-Controlled Trial

J. Borer, K. Fox, P. Jaillon, 2003, Circulation.